Anzavir-R™ is a licensed generic of Reyataz® (atazanavir) + Norvir® (ritonavir) produced in an FDA-approved factory in India. It’s a fixed-dose combination medicine used to treat HIV-1 in adult patients in conjunction with other antiretrovirals (ARVs).
- Anzavir-R™ provides a cost-effective WHO-approved second-line treatment option for people living with HIV/AIDS
Reviews
There are no reviews yet.